Massachusetts General Hospital; Dana Farber Partnes Cancer Center — Boston, Massachusetts

Massachusetts General Hospital; Dana Farber Partnes Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital; Dana Farber Partnes Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Sarcoma.

Sponsors: Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital; Dana Farber Partnes Cancer Center?

Massachusetts General Hospital; Dana Farber Partnes Cancer Center has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital; Dana Farber Partnes Cancer Center conducted?

Massachusetts General Hospital; Dana Farber Partnes Cancer Center has 1 clinical trials on record. Their work covers Sarcoma.

Is Massachusetts General Hospital; Dana Farber Partnes Cancer Center accredited by Crixeo Clinical Trials?

Massachusetts General Hospital; Dana Farber Partnes Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital; Dana Farber Partnes Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.